ag-Ip-news

The Only Specialized Global Intellectual Property News Agency
A Member of Talal Abu-Ghazaleh Organization
Arabic
Advanced Search
Mailing List Sign Up
Enter your e-mail address to receive daily headlines.

Unsubscribe
Click here for World Law news from NewsNow.co.uk
WAP Service


AGIPNEWS6746

3/2/2009 09:37 GMT
ag-IP-news
JFDA Seizes Counterfeit Medicines, Shuts Down 180 Pharmacies in Jordan

Special to ag-IP-news Agency

AMMAN - The Jordan Food and Drug Administration (JFDA) has closed down a total of 180 pharmacies after seizing counterfeit pharmaceuticals in addition to medications stolen from the Ministry of Health during the past two years, according to Al-Rai daily newspaper.

The JFDA General Manager Dr. Mohammad Al-Rawashdeh told Al-Rai that the total value of the confiscated medications reached up to JD17 million, and the violators have been referred to court.

According to the JFDA, the number of licensed pharmacies in the Kingdom totals 1800.

Al-Rawashdeh noted that the Public Health Law and in particular its articles concerning counterfeit and smuggled medications facilitated the process of red-handedly catching the violators, adding that the Administration has licensed 6500 brands of pharmaceuticals in the Kingdom.


Related Articles
Jordan Expected to Reduce Trademark Official Fees
TAG-Org and CFTC Sign Cooperation Agreement to Promote Chinese Jordanian Trade Exchange
Jordan Expected to Reduce Official Trademark Fees
Jordan Prepares the Amending Cyber Crimes Draft Law 2009
Jordanian Official Fees for Trademark Transactions Skyrocket
TAG-Org Launches Creative Commons-Jordan Today
Patent Drafting Workshop Kicks Off Tomorrow at the RSS
QRCE Announces the “Made in Jordan” Competition 2009 Winners
Trademark Registrations Go Up in Jordan
Towards a Modern Competition Law for Jordan Workshop Calls for Enforcing Modern Economic Legislations

Top
Go

Home | About Us | How to Use Our Services | Links | Download Our News Ticker | FAQ | What is IP? | Contact Us
Copyright © 2008 ag-IP-news All Rights Reserved
Disclaimer   Terms of Use    Privacy Policy